Article
Pneumocystis jiroveci dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae.
Antimicrobial agents and chemotherapy - 1 Jul 2004
Meneau I, Sanglard D, Bille J, Hauser P M
Abstract excerpt
Failure of anti-Pneumocystis jiroveci prophylaxis with sulfa drugs is associated with mutations within the putative active site of the fungal dihydropteroate synthase (DHPS), an enzyme encoded by the multidomain FAS gene. This enzyme is involved in the essential biosynthesis of folic acid. The most frequent polymorphisms are two mutations leading to two amino acid changes ((55)Trp-Arg-(57)Pro to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
